Loblaw Companies Ltd (L.TO)
Investor Insights
Jun 24, 2026, 12:00 am This summary was created by AI, based on 15 opinions in the last 12 months.
Loblaw Companies Ltd. is Canada's leading food and drug retailer, effectively navigating challenges posed by inflation and competition. Analysts commend its strategic focus on discount formats like No Frills and the strong performance of its private labels, particularly the No Name brand. The acquisition of Shoppers Drug Mart has proven beneficial, generating robust free cash flow, and establishing a solid market position with organic growth prospects. While some experts express concerns about its current valuation being high, the company remains a reliable defensive choice in uncertain economic times. Overall, experts acknowledge its significant market share, operational efficiencies, and impressive revenue growth despite mixed sentiment regarding its valuation relative to competitors.
Loblaw Companies Ltd (L.TO) Frequently Asked Questions
What is Loblaw Companies Ltd stock symbol?
Loblaw Companies Ltd is a Canadian stock, trading under the symbol L.TO (previously L-T on Stockchase) on the Toronto Stock Exchange (L-CT). It is usually referred to as TSX:L or L.TO
Is Loblaw Companies Ltd a buy or a sell?
In the last year, 14 stock analysts issued a Buy, Sell, or Hold rating on L.TO (previously L-T on Stockchase). 6 analysts recommended to BUY and 4 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Loblaw Companies Ltd.
Is Loblaw Companies Ltd worth watching?
Loblaw Companies Ltd is followed by 323 investors on Stockchase and is a trending stock that is worth watching.
What is Loblaw Companies Ltd stock price?
On 2026-06-24, Loblaw Companies Ltd (L.TO) stock closed at a price of $66.20.